The event is over. See you in the next one.
About this event
Why Attend?
Have questions you'd like addressed during the Q&A? Please send them in advance to: leyla.kragten@juliusclinical.com
Meet Our Panel:
Host:
Speakers:
Hosted by
MPH, DSc Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark Vera Ehrenstein is professor of phase IV studies at the Department of Clinical Epidemiology, Aarhus University, Denmark. She has led numerous multi-database, international epidemiologic studies of safety of medicines in pregnancy. She has served on the Board of Directors of the International Society for Pharmacoepidemiology (ISPE) and has recently joined the Editorial Board of Pharmacoepidemiology and Drug Safety. Vera is a member of the Steering Group of the European Network of Centres for Pharmacoepidemiology & Pharmacovigilance (ENCePP) under the aegis of the European Medicines Agency. Vera Ehrenstein is part of the taskforce of international experts charged with developing regulatory guidance on reproductive and perinatal pharmacoepidemiology. Vera Ehrenstein teaches "Topics in perinatal pharmacoepidemiology" on Thursday 19 June 2025 together with Irene Petersen.
Dr. Goodale brings 15+ years of clinical research experience, applying machine learning and advanced statistics to healthcare, vaccines, and drug development. She earned a PhD in quantitative and social psychology from UCLA in 2018, after a BA from Harvard in 2009. In 2017, she joined a wearable device company as a Data Science intern, later becoming a Clinical Data Scientist, where she authored regulatory documentation for fertility-predicting SaMD algorithms. Dr. Goodale has led retrospective Real World Evidence studies, systematic reviews, and contributed to numerous research projects. As Head of Data Science at Julius Clinical (2022–2024), she helped launch a post-market COVID-19 vaccine safety study via VAC4EU and worked to integrate AI into risk-based monitoring and project management. Her research spans infectious disease, cardiometabolic health, women’s health, and CNS, combining machine learning with epidemiological methods.
MSc, PhD Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Denmark Signe Sørup is a vaccine epidemiologist committed to studying the overall health effects of vaccines by using information from registers and other electronic databases. The main focus of her research has been safety and non-specific effects of vaccines, but her research interests also cover infectious diseases and vaccine uptake. Signe Sørup has been scientific coordinator of a joint NordForsk-funded register-based research project to examine the overall health effects of childhood vaccines for children in Denmark, Finland, Norway, and Sweden. She is a co-PI of a post-authorization active surveillance safety study of the Moderna COVID-19 vaccine conducted in 4 European countries. Signe Sørup has served as a board member for the Danish Society of Epidemiology.
Julius Clinical is the Academic Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world.
